VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SUPN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SUPNSupernus Pharmaceuticals, Inc.
$47.41$2.7B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSUPNQuarterly Financials

Supernus Pharmaceuticals, Inc. (SUPN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Supernus Pharmaceuticals, Inc. (SUPN) quarterly income statement — complete revenue, gross profit & net income history

SUPN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue207.71M211.57M192.1M165.45M149.82M174.16M175.69M168.32M143.64M164.31M153.88M135.56M153.76M167.33M177.35M170.05M152.51M159.05M148.46M141.33M
Revenue Growth %38.63%21.48%9.34%-1.71%4.3%5.99%14.17%24.17%-6.58%-1.8%-13.24%-20.28%0.82%5.2%19.46%20.32%16.48%10.79%-4.3%11.52%
Cost of Goods Sold23.39M23.01M18.96M16.83M15.76M26.1M17.58M17.92M16.31M19.63M19.6M21.09M23.46M22.95M25.88M20.46M17.93M16.99M18.09M25.03M
COGS % of Revenue11.26%10.87%9.87%10.17%10.52%14.99%10.01%10.64%11.35%11.94%12.74%15.56%15.26%13.72%14.59%12.03%11.76%10.68%12.18%17.71%
Gross Profit184.31M188.56M173.14M148.63M134.06M148.06M158.11M150.41M127.33M144.69M134.28M114.47M130.3M144.37M151.47M149.59M134.57M142.06M130.38M116.3M
Gross Margin %88.74%89.13%90.13%89.83%89.48%85.01%89.99%89.36%88.65%88.06%87.26%84.44%84.74%86.28%85.41%87.97%88.24%89.32%87.82%82.29%
Gross Profit Growth %37.49%27.36%9.51%-1.19%5.28%2.33%17.74%31.39%-2.28%0.22%-11.35%-23.48%-3.17%1.63%16.18%28.63%16.03%13.62%-2.52%-1.73%
Operating Expenses192.65M174.74M233.37M136.49M144.32M126.66M117.26M127.84M130.49M145.68M126.14M132.06M125.13M110.04M153M138.25M132.61M135.96M97.78M82.19M
OpEx % of Revenue92.75%82.59%121.48%82.49%96.32%72.72%66.74%75.95%90.84%88.66%81.97%97.42%81.38%65.76%86.27%81.3%86.95%85.48%65.86%58.15%
Selling, General & Admin125.17M122.39M179.68M93.55M89.94M79.41M69.75M85.9M86.52M81.28M82.7M86.78M85.6M73.97M112.31M100.48M90.46M101.73M72.03M69.53M
SG&A % of Revenue60.26%57.85%93.53%56.54%60.03%45.6%39.7%51.03%60.23%49.47%53.74%64.02%55.67%44.21%63.33%59.09%59.31%63.96%48.52%49.2%
Research & Development39.44M27.83M29.37M22.11M26.93M28.65M29.04M26.18M24.93M23.35M22.66M24.38M21.21M17.77M19.55M16.39M20.84M21.08M19.65M15.46M
R&D % of Revenue18.99%13.15%15.29%13.37%17.97%16.45%16.53%15.55%17.36%14.21%14.72%17.98%13.8%10.62%11.03%9.64%13.66%13.25%13.24%10.94%
Other Operating Expenses1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K-1000K
Operating Income-8.33M13.82M-60.23M12.14M-10.26M21.41M40.84M22.57M-3.15M-996K8.14M-17.59M5.18M34.33M-1.52M11.35M1.97M6.1M32.6M34.11M
Operating Margin %-4.01%6.53%-31.35%7.34%-6.85%12.29%23.25%13.41%-2.2%-0.61%5.29%-12.97%3.37%20.52%-0.86%6.67%1.29%3.83%21.96%24.14%
Operating Income Growth %18.76%-35.43%-247.46%-46.2%-225.28%2249.1%401.9%228.33%-160.92%-102.9%634.34%-255.01%163.14%463.04%-104.67%-66.74%-85.11%-85.82%-41.92%-25.11%
EBITDA-8.33M38.84M-35.42M33.5M10.13M40.25M60.95M43.29M17.6M20.68M30M3.14M25.78M55.18M20.25M32.9M23.33M18.8M39.28M40.73M
EBITDA Margin %-4.01%18.36%-18.44%20.25%6.76%23.11%34.69%25.72%12.25%12.59%19.49%2.31%16.76%32.98%11.42%19.35%15.3%11.82%26.46%28.82%
EBITDA Growth %-182.28%-3.51%-158.12%-22.61%-42.45%94.63%103.19%1279.45%-31.74%-62.52%48.11%-90.46%10.49%193.45%-48.44%-19.22%17.79%-61.24%-38.61%-16.17%
D&A (Non-Cash Add-back)025.02M24.81M21.36M20.38M18.84M20.1M20.72M20.75M21.68M21.86M20.73M20.6M20.85M21.77M21.56M21.36M12.71M6.67M6.62M
EBIT-8.33M1.66M-60.23M12.14M-2.6M26.38M44.94M18.21M-4.25M990K9.89M-16.22M10.52M36.73M1.28M13.13M16.66M7.99M34.88M36.7M
Net Interest Income02.02M2.28M4.53M4.42M4.98M4.1M3.73M3.4M1.99M1.75M460K3.84M806K1.08M-22K12.76M-4.05M-3.64M-2.88M
Interest Income02.02M2.28M4.53M4.42M4.98M4.1M3.73M3.4M1.99M1.75M1.37M5.35M2.4M2.8M1.79M14.7M1.89M2.28M2.59M
Interest Expense00000000000910K1.5M1.59M1.72M1.81M1.94M5.93M5.92M5.47M
Other Income/Expense2.38M-15.74M2.28M4.53M4.42M4.98M4.1M3.73M3.4M1.99M1.75M460K3.84M806K1.08M-22K12.76M-4.05M-3.64M-2.88M
Pretax Income-5.95M-1.91M-57.95M16.67M-5.83M26.38M44.94M26.3M243K990K9.89M-17.13M9.02M35.14M-444K11.32M14.72M2.05M28.96M31.23M
Pretax Margin %-2.86%-0.9%-30.17%10.07%-3.89%15.15%25.58%15.63%0.17%0.6%6.43%-12.63%5.86%21%-0.25%6.66%9.65%1.29%19.51%22.1%
Income Tax-3.66M2.19M-12.84M-5.83M6M11.05M6.45M6.39M119K-185K25.86M-16.3M-7.93M9.66M-2.19M3.46M-10.89M-391K7.4M7.51M
Effective Tax Rate %61.46%-114.47%22.15%-34.98%-102.83%41.9%14.34%24.28%48.97%-18.69%261.55%95.15%-87.96%27.49%493.92%30.55%-73.99%-19.06%25.55%24.04%
Net Income-2.29M-4.11M-45.12M22.5M-11.83M15.33M38.5M19.92M124K1.18M-15.98M-831K16.95M25.48M1.75M7.87M25.62M2.44M21.56M23.73M
Net Margin %-1.1%-1.94%-23.49%13.6%-7.89%8.8%21.91%11.83%0.09%0.72%-10.38%-0.61%11.02%15.23%0.99%4.63%16.8%1.54%14.52%16.79%
Net Income Growth %80.61%-126.78%-217.2%12.97%-9637.9%1204.51%340.97%2496.63%-99.27%-95.39%-1013.44%-110.57%-33.84%943.45%-91.89%-66.85%349.88%-92.06%-46.09%-31.56%
Net Income (Continuing)-2.29M-4.11M-45.12M22.5M-11.83M15.33M38.5M19.92M124K1.18M-15.98M-831K16.95M25.48M1.75M7.87M25.62M2.44M21.56M23.73M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.04-0.07-0.800.40-0.210.270.690.360.000.02-0.29-0.020.290.430.030.140.430.040.400.43
EPS Growth %80.95%-126.52%-215.94%11.11%-1167.61%337.93%1900%-99.31%-95.05%-1066.67%-114.29%-32.56%975%-92.5%-67.44%290.91%-92.98%-45.95%-33.85%
EPS (Basic)-0.04-0.07-0.800.40-0.210.280.700.360.000.02-0.29-0.020.310.470.030.150.480.050.410.45
Diluted Shares Outstanding57.65M57.34M56.55M56.64M55.86M56.46M56.02M55.72M55.63M55.06M54.61M54.5M62.45M62.09M55.03M61.4M61.41M54.53M54.33M54.72M
Basic Shares Outstanding57.65M57.34M56.4M56.02M55.86M55.47M55.15M54.98M54.8M54.57M54.61M54.5M54.38M54.1M53.79M53.43M53.33M53.24M53.19M53.01M
Dividend Payout Ratio--------------------